A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors

Several obstacles to the production, expansion and genetic modification of immunotherapeutic T cells in vitro have restricted the widespread use of T-cell immunotherapy. In the context of HSCT, delayed naïve T-cell recovery contributes to poor outcomes. A novel approach to overcome the major limitat...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cell Mol Immunol
Κύριοι συγγραφείς: Moirangthem, Ranjita Devi, Ma, Kuiying, Lizot, Sabrina, Cordesse, Anne, Olivré, Juliette, de Chappedelaine, Corinne, Joshi, Akshay, Cieslak, Agata, Tchen, John, Cagnard, Nicolas, Asnafi, Vahid, Rausell, Antonio, Simons, Laura, Zuber, Julien, Taghon, Tom, Staal, Frank J. T., Pflumio, Françoise, Six, Emmanuelle, Cavazzana, Marina, Lagresle-Peyrou, Chantal, Soheili, Tayebeh, André, Isabelle
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Nature Publishing Group UK 2021
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8245454/
https://ncbi.nlm.nih.gov/pubmed/34117371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-021-00706-8
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια